首页> 外文期刊>Online journal of biological sciences >Inhibition of U6 snRNA Transcription by PTEN
【24h】

Inhibition of U6 snRNA Transcription by PTEN

机译:PTEN抑制U6 snRNA转录

获取原文
获取原文并翻译 | 示例
       

摘要

Problem statement: RNA polymerase III (RNA pol III) is responsible for transcribing many of the small structural RNA molecules involved in RNA processing and protein translation, thereby regulating the growth rate of a cell. RNA pol III transcribes both gene internal (tRNA) and gene external (U6 snRNA) promoters and proper initiation by RNA polymerase III requires the transcription initiation factor TFIIIB. TFIITB has been shown to be a target of repression by tumor suppressors such as ARF, p53, RB and the RB-related pocket proteins. Also, TFIIIB activity is stimulated by the oncogenes c-Myc and the ERK mitogen-activated protein kinase. Recently, two TFIIIB subunits, BRF1 and BRF2, have been demonstrated to behave as oncogenes, making deregulation of TFIIIB activity and thus RNA pol III transcription an important step in tumor development. PTEN is a commonly mutated tumor suppressor regulating cell growth, proliferation and survival. Thus, we sought to examine the potential role of PTEN in regulating U6 snRNA transcription. Approach: We examined the potential for PTEN to regulate U6 snRNA transcription using in vitro RNA pol III luciferase assays, western blotting and deletion analysis in cancer cell lines differing in their PTEN status. Results:Using breast, cervical, prostate and glioblastoma cancer cells we demonstrate: (1) PTEN inhibition of gene external RNA pol III transcription is cell type specific, (2) PTEN-mediated inhibition of U6 transcription occurs via the C2 lipid-binding domain and (3) PTEN repression of U6 transcription occurs, at least in part, through the TFIIIB subunit BRF2. Conclusion/Recommendations: Our data demonstrates that regulation of the U6 snRNA gene by PTEN is mediated, in part by the TFIIIB oncogene BRF2, potentially identifying novel targets for chemotherapeutic drug design.
机译:问题陈述:RNA聚合酶III(RNA pol III)负责转录许多参与RNA加工和蛋白质翻译的小结构RNA分子,从而调节细胞的生长速度。 RNA pol III转录基因内部(tRNA)和基因外部(U6 snRNA)启动子,通过RNA聚合酶III正确启动需要转录启动因子TFIIIB。 TFIITB已被证明是肿瘤抑制因子(如ARF,p53,RB和RB相关口袋蛋白)的抑制靶标。此外,癌基因c-Myc和ERK丝裂原激活的蛋白激酶刺激TFIIIB活性。最近,已证明两个TFIIIB亚基BRF1和BRF2充当致癌基因,从而使TFIIIB活性的失控以及RNA pol III转录成为肿瘤发展中的重要步骤。 PTEN是通常突变的肿瘤抑制因子,可调节细胞的生长,增殖和存活。因此,我们试图检查PTEN在调节U6 snRNA转录中的潜在作用。方法:我们使用体外RNA pol III荧光素酶测定法,蛋白质印迹法和在其PTEN状态不同的癌细胞系中的缺失分析,检查了PTEN调节U6 snRNA转录的潜力。结果:使用乳腺癌,宫颈癌,前列腺癌和胶质母细胞瘤癌细胞,我们证明:(1)PTEN对基因外部RNA pol III转录的抑制是细胞类型特异性的;(2)PTEN介导的对U6转录的抑制是通过C2脂质结合域发生的(3)至少部分通过TFIIIB亚基BRF2发生U6转录的PTEN抑制。结论/建议:我们的数据表明,PTEN对U6 snRNA基因的调节部分是由TFIIIB癌基因BRF2介导的,有可能为化疗药物设计确定新的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号